These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 30470994)

  • 1. Impact of systemic inflammation biomarkers on the survival outcomes of cervical cancer patients.
    Holub K; Biete A
    Clin Transl Oncol; 2019 Jul; 21(7):836-844. PubMed ID: 30470994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
    Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
    J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unveiling the mechanisms of immune evasion in pancreatic cancer: may it be a systemic inflammation responsible for dismal survival?
    Holub K; Conill C
    Clin Transl Oncol; 2020 Jan; 22(1):81-90. PubMed ID: 31004253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New pre-treatment eosinophil-related ratios as prognostic biomarkers for survival outcomes in endometrial cancer.
    Holub K; Biete A
    BMC Cancer; 2018 Dec; 18(1):1280. PubMed ID: 30577833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of outcomes in inflammatory breast cancer.
    Al Jarroudi O; El Bairi K; Abda N; Zaimi A; Jaouani L; Chibani H; Afqir S
    Biomark Med; 2021 Oct; 15(14):1289-1298. PubMed ID: 34486882
    [No Abstract]   [Full Text] [Related]  

  • 6. Pre-treatment inflammatory indexes as predictors of survival and cetuximab efficacy in metastatic colorectal cancer patients with wild-type RAS.
    Yang J; Guo X; Wang M; Ma X; Ye X; Lin P
    Sci Rep; 2017 Dec; 7(1):17166. PubMed ID: 29215037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative prognostic nutritional index and systemic immune-inflammation index predict survival outcomes in osteosarcoma: A comparison between young and elderly patients.
    Ma C; Yu R; Li J; Guo J; Xu J; Wang X; Liu P
    J Surg Oncol; 2022 Mar; 125(4):754-765. PubMed ID: 34811745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A High Monocyte-to-Lymphocyte Ratio Predicts Poor Prognosis in Patients with Advanced Gallbladder Cancer Receiving Chemotherapy.
    Choi YH; Lee JW; Lee SH; Choi JH; Kang J; Lee BS; Paik WH; Ryu JK; Kim YT
    Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1045-1051. PubMed ID: 30842131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of Preoperative Systemic Immunoinflammatory Measures in Patients with Esophageal Cancer.
    Ishibashi Y; Tsujimoto H; Hiraki S; Kumano I; Yaguchi Y; Horiguchi H; Nomura S; Ito N; Shinto E; Aosasa S; Yamamoto J; Ueno H
    Ann Surg Oncol; 2018 Oct; 25(11):3288-3299. PubMed ID: 30019304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative neutrophil-lymphocyte ratio before platelet-lymphocyte ratio predicts clinical outcome in patients with cervical cancer treated with initial radical surgery.
    Zhang Y; Wang L; Liu Y; Wang S; Shang P; Gao Y; Chen X
    Int J Gynecol Cancer; 2014 Sep; 24(7):1319-25. PubMed ID: 25033256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment neutrophil-lymphocyte and platelet-lymphocyte ratio predict clinical outcome and prognosis for cervical Cancer.
    Zhu M; Feng M; He F; Han B; Ma K; Zeng X; Liu Z; Liu X; Li J; Cao H; Liang Y; Jia C; Zhang L
    Clin Chim Acta; 2018 Aug; 483():296-302. PubMed ID: 29758203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic inflammation scores correlate with survival prognosis in patients with newly diagnosed brain metastases.
    Starzer AM; Steindl A; Mair MJ; Deischinger C; Simonovska A; Widhalm G; Gatterbauer B; Dieckmann K; Heller G; Preusser M; Berghoff AS
    Br J Cancer; 2021 Mar; 124(7):1294-1300. PubMed ID: 33473170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and their dynamic changes during chemotherapy is useful to predict a more accurate prognosis of advanced biliary tract cancer.
    Cho KM; Park H; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
    Oncotarget; 2017 Jan; 8(2):2329-2341. PubMed ID: 27911876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study.
    Toyokawa T; Kubo N; Tamura T; Sakurai K; Amano R; Tanaka H; Muguruma K; Yashiro M; Hirakawa K; Ohira M
    BMC Cancer; 2016 Sep; 16(1):722. PubMed ID: 27599460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral platelet/lymphocyte ratio predicts lymph node metastasis and acts as a superior prognostic factor for cervical cancer when combined with neutrophil: Lymphocyte.
    Chen L; Zhang F; Sheng XG; Zhang SQ; Chen YT; Liu BW
    Medicine (Baltimore); 2016 Aug; 95(32):e4381. PubMed ID: 27512849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio at Day +100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?
    Solmaz Medeni S; Acar C; Olgun A; Acar A; Seyhanlı A; Taskıran E; Sevindik OG; Alacacıoglu I; Piskin O; Ozcan MA; Demirkan F; Undar B; Ozsan GH
    Clin Transplant; 2018 Sep; 32(9):e13359. PubMed ID: 30053318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment Inflammation-Based Markers Predict Survival Outcomes in Patients with Early Stage Hepatocellular Carcinoma After Radiofrequency Ablation.
    Chu MO; Shen CH; Chang TS; Xu HW; Yen CW; Lu SN; Hung CH
    Sci Rep; 2018 Nov; 8(1):16611. PubMed ID: 30413724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
    Deng M; Ma X; Liang X; Zhu C; Wang M
    Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer.
    Lian L; Xia YY; Zhou C; Shen XM; Li XL; Han SG; Zheng Y; Mao ZQ; Gong FR; Wu MY; Chen K; Tao M; Li W
    Cancer Biomark; 2015; 15(6):899-907. PubMed ID: 26444485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of neutrophil-to-lymphocyte ratio in early-stage ovarian clear-cell carcinoma.
    Yoshida K; Yoshikawa N; Shirakawa A; Niimi K; Suzuki S; Kajiyama H; Kikkawa F
    J Gynecol Oncol; 2019 Nov; 30(6):e85. PubMed ID: 31576683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.